{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Obstetrical & Gynecological Survey - Vol. 73, No. 2

Activity Steps

1 Activity
2 Take Test 3Certificate

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. CME 4: Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management--Identify symptoms of and diagnose ICP, counsel patients on neonatal risks associated with the diagnosis of ICP, and provide treatment for women with a diagnosis of ICP.
  2. CME 5: Pelvic Packing for Intractable Obstetric Hemorrhage After Emergency Peripartum Hysterectomy: A Review--Identify the situations were pelvic packing could be used as a lifesaving procedure; compare the different techniques of pelvic packing, highlighting the potential advantages and disadvantages of each technique; and evaluate the success rate of the procedure and the potential morbidity.
  3. CME 6: Evaluation and Management of Maternal Congenital Heart Disease: A Review--Compare pregnancy risks among varying types of the most common maternal CHD; apply criteria of relative and absolute contraindications to pregnancy when performing preconception counseling to women with CHD; interpret for patients and other health providers the prognosis, management, and expectations of pregnancies with women with the most common types of CHD; and select relevant imaging studies, tests, and appropriate consultations and referrals when caring for women with maternal CHD.

Disclosures

The authors, faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interest in, any commercial organizations pertaining to this educational activity.

OFF-LABEL STATEMENT

CME ARTICLE 4: The authors have disclosed that the US Food and Drug Administration has not approved the use of ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy as discussed in this article. Please consult the product's labeling for approved information.

Price: $30.00

Credits:

  • ACCME 3.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 3.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Planner
Professions: Physician
Test Code: OGS0218
Published: February 2018
Expires: 1/1/2026
Sources: Obstetrical & Gynecological Survey
Required Passing Score: 9/12 (75%)
Authors: Amber M. Wood, MD, Elizabeth G. Livingston, MD, Brenna L. Hughes, MD, and Jeffrey A. Kuller, MD; Omar Touhami, MD, Arij Bouzid, MD, Sofiene Ben Marzouk, MD, Mahdi Kehila, MD, Mohamed Badis Channoufi, MD, and Hayen El Magherbi, MD; Maeve K. Hopkins, MD, MA, Sarah A. Goldstein, MD, Cary C. Ward, MD, and Jeffrey A. Kuller, MD
Categories: Intrahepatic Cholestasis of Pregnancy , Maternal Congenital Heart Disease , Peripartum Hysterectomy
Specialties: OB/GYN
Topics: Congenital Heart Disease , Intrahepatic Cholestasis of Pregnancy , Pelvic Packing for Intractable Obstetric Hemorrhage